Specificity for the D835Y substitution of FLT3 was demonstrated by lack of recognition of AML samples with alternative amino acid substitutions in the D835 position (patients 9 and 10) or expressing FLT3WT (patient 11) (Fig. 2d and Supplementary Table 2). This evidence concerns the gene FLT3 and acute myeloid leukemia.